According to the most recent report by Emergen Research, the size of the worldwide organ on a chip market is anticipated to reach USD 209.4 Million in 2028, growing at a steady CAGR of 28.1%.
According to the most recent report by Emergen Research, the size of the worldwide organ on a chip market is anticipated to reach USD 209.4 Million in 2028, growing at a steady CAGR of 28.1%. Growing demand for organ on a chip for medication development and screening to lessen financial losses related to drug failures can be contributed to the steady market revenue growth. Pharmaceutical and biotechnology businesses are gaining a lot of interest in organ on a chip because of its affordability, tiny scale, and precise control over the mechanical and chemical microenvironment, which helps lower the failure rate of medications.
It is a multichannel 3D micro-fluidic cell culture apparatus that stimulates the physiological reactions, mechanisms, and activities of organs. A new model of in vitro multicellular human creatures has been developed as a result of the ability of researchers to analyse human physiology in an organ-specific environment using labs-on-chips (LOCs) and cell biology. This chip creates a small passageway for the blood and air to travel through many organs, including the heart, liver, brain, intestines, and lungs. These devices are built on a microchip with constantly perfused chambers populated by living cells and configured to stimulate physiology at the level of the tissues and organs. A silicone-based device called a "organ-on-chip" is utilised to foster internal organs.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/617
The demand for lung- and kidney-based organ culture devices as well as an increase in the demand for organ-on-chips in drug screening are anticipated to drive the market for these products. Additionally, it is anticipated that the lack of donor organs and the availability of functional organs created in a lab will be a huge advantage in meeting the expanding need for organ transplantation. However, the exorbitant price of the organ chip device and the fact that organ-on-chip (OOC) technology is still in its infancy are predicted to impede commercial expansion. On the other hand, a significant surge in healthcare spending around the world has increased the size of the market for organs on chips. The market for organs on chips has a lot of potential in emerging economies.
The synergistic fusion of tissue engineering and microfabrication technologies, according to CXOs, makes organs-on-chip prospective instruments for realistic modelling of human physiology and pathology. These technologies are anticipated to offer efficient answers to persistent problems in drug discovery and the treatment of certain diseases. Due to supportive government policies, rules that support organ-on-chip, and the expansion of alternatives to animal testing, the global market for organs on chips experienced substantial growth in the healthcare and pharmaceutical sectors. However, it is anticipated that the market growth will be constrained by the high development and manufacturing costs of organ-chip devices.
Some Key Highlights from the Report
- Key players in the market include MIMETAS BV, SynVivo Inc., Emulate Inc., InSphero AG, CN Bio, Nortis Inc., Organovo Holdings Inc., TissUse GmbH, AxoSim Inc., and Kirkstall Ltd.
- The market for organs on chips is driven by a number of causes, including the need for alternatives to animal testing, the requirement for early drug toxicity detection, new product introductions, and technological improvements. For instance, CN Bio and the University of Melbourne worked together in December 2020 to enhance therapeutics using lung-on-a-chip technology for respiratory difficulties in patients who have recovered from COVID-19.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/organs-on-chips-market
- Additionally, in October 2020, BioVox promoted organ-on-chip technology in an initiative to reduce animal testing and improve in vitro research models. In addition, AIM Biotech introduced the idenTx 40 Plate in November 2021, a high-throughput organ-on-a-chip system that enables biotechnology and pharmaceutical firms' researchers to accurately replicate the function of human organs and tissues without the use of animals for study.
- Due to fewer lung transplants, which has prompted the development of laboratory-engineered chips to mimic their functions and for drug screening for respiratory disorders, the lung-on-chip segment of the organ-on-chip industry dominated the market in 2020 and is predicted to continue dominating during the forecast period.
- In 2020, North America held the largest global market share for organs on chips, and it is expected to hold this position during the forecast period. This is attributable to a growth in the use of technologically advanced models, the presence of important players, and an increase in research and development operations for the development of new drugs. However, because to an increase in R&D efforts, an increase in healthcare spending, and diverse tactics among key competitors, the Asia-Pacific region is predicted to have a significant organ-on-chip market opportunity. In addition, according to the prediction for the Asia-Pacific organ-on-chip market, India and China would expand at rapid CAGRs.
FREQUENTLY ASKED QUESTIONS?
Q1. What is the estimated industry size of Organ-on-Chip?
A. The total market value of organ-on-chip market is USD 27.5 Million in 2020 in 2020.
Q2. What is the leading application of Organ-on-Chip Market?
A. Due to fewer lung transplants, which has prompted the creation of laboratory-engineered chips to imitate their functionalities and for drug screening for respiratory illnesses, the lung-on-chip category is likely to dominate the market in 2020 and continue to do so throughout the forecast period.
Q3. What are the upcoming trends of Organ-on-Chip Market in the world?
A. The market is expected to be driven by the expanding patient pool, rising frequency of chronic diseases, and numerous technological developments in organ-on-chip throughout the forecast period.
Q4. Which are the top companies to hold the market share in Organ-on-Chip?
A. Leading businesses retained a strong market position in 2020, including AxoSim Technologies LLC, BICO Group AB(Visikol), CN Bio Innovations Limited, Elveflow, Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems.
Q5. Which is the largest regional market for Organ-on-Chip?
A. During the forecast period, North America is anticipated to have a significant market share for organs on chips worldwide. Due to an increase in chronic diseases, the use of technologically enhanced medicines, and a spike in R&D nationwide, the U.S. dominated the North American organ-on-chip market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/617
Emergen Research has segmented the global organ on a chip market on the basis of type, application, end-use, and region:
Type Outlook (Revenue, USD Million; 2018–2028)
- Liver-on-Chip
- Multiple organ on a chip
- Kidney-on-Chip
- Heart-on-Chip
- Lung-on-Chip
- Intestine-on-Chip
- Others
Application Outlook (Revenue, USD Million; 2018–2028)
- Drug Discovery
- Physiological Model Development
- Toxicology Research
End-Use Outlook (Revenue, USD Million; 2018–2028)
- Pharmaceutical Firms
- Research Institutes
- Personal Care Industry
- Others
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/617
Explore More Reports Emergen Research:
Weather Forecasting Systems Market
Continuous Fiber Composites Market
Signal Conditioning Modules Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-organs-on-chips-market
Latest Published Titles Smart Cities Market | Smart Learning Market
Trending Titles Humanoid Robot Market | Incident Response Market